Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer

Listen to Nilofer S. Azad, MD, and Kanwal Raghav, MD, as they discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC.